Protecting the Heart During Cancer Therapy | Frontiers in Medicine
From Stanford Medicine · · 11 min

The player loads from YouTube only when you click. It uses YouTube's privacy-enhanced mode.
If the video does not play, the owner may have turned off embedding. Watch it on YouTube instead.
Description
Han Zhu, MD Assistant Professor of Medicine–Cardiovascular Medicine
Protecting the Heart During Cancer Therapy
Cancer immunotherapies have transformed patient survival, yet these same life-saving treatments can themselves cause life-threatening inflammation of the heart, a condition called myocarditis. Cardiologist Han Zhu is working with oncologists across every cancer specialty to solve this problem. Learn about how her lab discovered the first biological roadmap of immunotherapy-induced myocarditis and is developing one of the first targeted therapeutic strategies—a groundbreaking effort that could transform how clinicians worldwide safeguard patients’ hearts during cancer treatment.
Read Guardians of the heart: Reducing cardiotoxicity in cancer treatment (Stanford Cancer Institute): https://med.stanford.edu/cancer/about/news/cardiotoxicity.html
Part of Stanford Medicine's Frontiers in Medicine 2026. Visit frontiersinmedicine.stanford.edu to learn more.